Plant Lectins, from Ancient Sugar-Binding Proteins to Emerging Anti-Cancer Drugs in Apoptosis and Autophagy.

Q-L Jiang,S Zhang,M Tian,S-Y Zhang,T Xie,D-Y Chen,Y-J Chen,J He,J Liu,L Ouyang,X Jiang
DOI: https://doi.org/10.1111/cpr.12155
IF: 8.755
2014-01-01
Cell Proliferation
Abstract:Ubiquitously distributed in different plant species, plant lectins are highly diverse carbohydrate-binding proteins of non-immune origin. They have interesting pharmacological activities and currently are of great interest to thousands of people working on biomedical research in cancer-related problems. It has been widely accepted that plant lectins affect both apoptosis and autophagy by modulating representative signalling pathways involved in Bcl-2 family, caspase family, p53, PI3K/Akt, ERK, BNIP3, Ras-Raf and ATG families, in cancer. Plant lectins may have a role as potential new anti-tumour agents in cancer drug discovery. Thus, here we summarize these findings on pathway- involved plant lectins, to provide a comprehensive perspective for further elucidating their potential role as novel anti-cancer drugs, with respect to both apoptosis and autophagy in cancer pathogenesis, and future therapy.
What problem does this paper attempt to address?